Product Details for: Alyglo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
10% 100MG/ML
Single-Dose Vial
351(a)
Alyglo
Rx
Proper Name
immune globulin intravenous, human-stwk
BLA Number
125743
Applicant
GC Biopharma Corp.
Original Approval Date
December 15, 2023
Date of First Licensure
RETURN TO SEARCH RESULTS